RIP1-mediated resistance of melanoma cells to BRAF/MEK inhibitors was due to its inhibitory effect on induction of apoptosis, as RIP1 silencing promoted activation of the caspase cascade and a general caspase inhibitor abolished enhancement of killing of melanoma by silencing of RIP1. The gene discussed is RIPK1; the disease is melanoma.